Effect of Bordetella pertussis vaccine on the course of lymphocytic choriomeningitis (LCM) virus infection in suckling mice pretreated with dianhydrodulcitol (DAD).
In earlier experiments Bordetella pertussis vaccine was found to enhance and dianhydrodulcitol (DAD) to weaken cellular immune response to intracerebral LCM virus infection in suckling mice. B. pertussis vaccine proved to inhibit the restrictive effect of DAD produced on the immune response in mice when 2-to-4-days-old animals were pretreated with DAD and subsequently, at the age of 16 to 18 days of life, treated with B. pertussis vaccine then infected with LCM virus. Consequently, B. pertussis vaccine enhanced the immune response previously affected by DAD.
D000818:Animals; D000833:Animals, Suckling; D003961:Dianhydrogalactitol / Q000627:therapeutic use*; D005260:Female; D008216:Lymphocytic Choriomeningitis / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D008297:Male; D051379:Mice; D009929:Organ Size; D010567:Pertussis Vaccine / Q000627:therapeutic use*; D013154:Spleen / Q000473:pathology; D013402:Sugar Alcohols / Q000627:therapeutic use*
D010567:Pertussis Vaccine; D013402:Sugar Alcohols; D003961:Dianhydrogalactitol